SolAeroMed, Inc.
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.solaeromed.com
Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.
Phase 2
- Conditions
- COVID-19 Respiratory InfectionPost Acute COVID-19 SyndromeLong COVID
- Interventions
- Drug: S-1226 (8%)Other: Placebo
- First Posted Date
- 2021-07-02
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- SolAeroMed Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04949386
Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- SolAeroMed Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04738136
- Locations
- π¨π¦
Alberta Lung Function, Calgary, Alberta, Canada
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
- First Posted Date
- 2019-04-04
- Last Posted Date
- 2021-06-16
- Lead Sponsor
- SolAeroMed Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03903913
- Locations
- π¨π¦
Pediatric Cystic Fibrosis Clinic at Alberta Children's Hospital, Calgary, Alberta, Canada
π¨π¦Alberta Lung Function, Calgary, Alberta, Canada
π¨π¦Adult Cystic Fibrosis Clinic at the Foothills Hospital, Calgary, Alberta, Canada
Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.
Phase 1
Completed
- Conditions
- Asthma
- Interventions
- Drug: Saline (for 12%)Drug: Saline (for 4%)Drug: Saline (for 8%)Drug: S1226 (4%)Drug: S1226(8%)Drug: S1226(12%)
- First Posted Date
- 2015-11-30
- Last Posted Date
- 2015-11-30
- Lead Sponsor
- SolAeroMed Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT02616770
Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma
Phase 2
Completed
- Conditions
- Asthma
- Interventions
- Drug: S1226(8%)Drug: Placebo
- First Posted Date
- 2015-01-08
- Last Posted Date
- 2019-02-18
- Lead Sponsor
- SolAeroMed Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02334553
- Locations
- π¨π¦
Respiratory Clinical Trials Centre, University of Calgary, Calgary, Alberta, Canada
Β© Copyright 2025. All Rights Reserved by MedPath